Home | Vincerx Pharma
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 Read More
Vincerx Pharma, Inc. (VINC) - Yahoo Finance
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States.
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data
1 day ago · --Vincerx Pharma, Inc., a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, and Oqory, Inc., a private ...
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for …
1 day ago · SAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through ...
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising
1 day ago · Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company committed to developing differentiated and novel therapies to address the unmet medical needs of patients with cancer.
Vincerx Pharma, Inc. Announces Reverse Stock Split
3 days ago · Vincerx’s Common Stock to Begin Trading on a Split-adjusted Basis on January 28, 2025 SAN MATEO, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that its board of …
VINC Stock Price | Vincerx Pharma Inc. Stock Quote (U.S.: Nasdaq ...
3 days ago · Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance...
Vincerx Pharma Enters into a Binding Term Sheet for a Strategic …
PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held ...
Vincerx Pharma, Inc. Announces Proposed Merger with Oqory, Inc.
Dec 27, 2024 · Vincerx Pharma, Inc. has announced a proposed merger with Oqory, Inc., a clinical-stage company developing antibody-drug conjugates (ADCs) for various cancer types.
Investor Relations - Vincerx Pharma
Vincerx Pharma is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
- Some results have been removed